Patient
|
CD138+ IgG4−
|
CD138+ IgG4+
|
CD138+
|
CD20+
|
CD3+
|
CD68+
|
Total
|
---|
Diagnostic biopsies
|
1
|
–
|
–
|
600
|
333.3
|
1381.8
|
635.3
|
2950.4
|
2
|
–
|
–
|
–
|
375.7
|
1808.7
|
–
| |
3 B1
|
808.4
|
52.2
|
860.6
|
668.4
|
1860.9
|
852.3
|
4241.6
|
4 B1
|
–
|
–
|
1439.2
|
–
|
–
|
–
| |
5
|
1595
|
40
|
1635
|
1157
|
2019.6
|
2507.3
|
7318.9
|
6
|
1553.5
|
797.9
|
2351.4
|
325.2
|
2116.6
|
1381.5
|
6174.7
|
7 B2
|
935.9
|
160
|
1095.9
|
837.5
|
641.2
|
374
|
2948.6
|
8
|
–
|
–
|
–
|
244,1
|
2051.2
|
–
| |
9
|
1658.9
|
88.3
|
1747.3
|
613.5
|
2422.7
|
114.9
|
4898.9
|
10
|
899
|
81.3
|
980.3
|
524.5
|
645.2
|
721.2
|
2871.3
|
11
|
599.8
|
89.5
|
689.4
|
735.6
|
1636.6
|
344.3
|
3405.9
|
12
|
286.7
|
533.3
|
820
|
400
|
1008.7
|
466.7
|
2695.3
|
Follow-up biopsies
|
3 B2
|
105.7
|
9.5
|
115.2
|
109.9
|
1296.1
|
630.8
|
215.2
|
4 B2
|
344.5
|
71.8
|
416.3
|
1591.2
|
3226.7
|
530
|
5764.2
|
Recurrent HCV prior to the development of dnIH
|
7 B1
|
227.1
|
154.2
|
381.3
|
295.8
|
838.1
|
779.6
|
2294.8
|
- Cell number is shown as cells/mm2
- PC, plasma cell; B1, biopsy 1; B2, biopsy 2